@charlesrudin.bsky.social
📤 27
đź“Ą 9
đź“ť 2
A big advance for patients with SCLC today —
www.nejm.org/doi/full/10....
loading . . .
Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy | NEJM
Tarlatamab, a bispecific delta-like ligand 3–directed T-cell engager immunotherapy, received accelerated approval for the treatment of patients with previously treated small-cell lung cancer. Wheth...
https://www.nejm.org/doi/full/10.1056/NEJMoa2502099
4 months ago
0
3
1
First Bluesky post… New paper out, following on FOXA observations of the
@juliensage.bsky.social
lab; nice collaboration with the
@joanmassague.bsky.social
lab led by a shared post-doc, Kenta Kawasaki
www.nature.com/articles/s41...
loading . . .
FOXA2 promotes metastatic competence in small cell lung cancer - Nature Communications
Small cell lung cancer presents high and multi-site metastatic potential. Here, the authors discover that FOXA2, regulated by ASCL1, promotes multi-site metastasis in small cell lung cancer by inducin...
https://www.nature.com/articles/s41467-025-60141-5?utm_source=rct_congratemailt&utm_medium=email&utm_campaign=oa_20250526&utm_content=10.1038/s41467-025-60141-5
4 months ago
0
4
2
you reached the end!!
feeds!
log in
